Phenotypic characters of urinary isolates of Pseudomonas aeruginosa & their association with mouse renal colonization

Indian Journal of Medical Research

Volumn 123, Issue 1, 2006, Pages 67-72

  Mittal, Rahul ^a   Khandwaha, Rakesh K ^a   Gupta, Varsha ^a   Mittal, P K ^b   Harjai, Kusum ^a  

^a PANJAB UNIVERSITY   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Mouse model; Pseudomonas aeruginosa; Urinary tract infections; Virulence factors

Indexed keywords

ALGINIC ACID; ELASTASE; HEMOLYSIN; PHOSPHOLIPASE C; PROTEINASE; PYOVERDINE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; QUANTITATIVE ANALYSIS; SEROTYPE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION;

ANIMALS; FEMALE; HEMOLYSIN PROTEINS; HEMOLYTIC AGENTS; KIDNEY; MICE; PHENOTYPE; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTIONS; URINE; VIRULENCE FACTORS;

EID: 33645465868     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Matar GM, Chaar MH, Araj GF, Srour Z, Jamaleddine G, Hadi U. Detection of a highly prevalent and potentially virulent strain of Pseudomonas aeruginosa from nosocomial infections in a medical center. BMC Microbiol 2005; 5 : 29-30.
2. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003; 49 : 71-82.
3. Williams DH, Schaeffer AJ. Current concepts in urinary tract infections. Minerva Urol Nefrol 2004; 56 : 15-31.
4. Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol 1986; 24 : 260-4.
5. Woods DE, Lam JS, Paranchych W, Speert DP, Campbell M, Godfrey AJ. Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse. Can J Microbiol 1997; 43 : 541-51.
6. Parks QM, Hobden JA. Polyphosphate kinase 1 and the ocular virulence of Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 2005; 46 : 248-51.
7. Davis KA, Santaniello JM, He LK, Muthu K, Sen S, Jones SB, et al. Burn injury and pulmonary sepsis: development of a clinically relevant model. J Trauma 2004; 56 : 272-8.
8. Visca P, Chiarini F, Mansi A, Vetriani C, Serino L, Orsi N. Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections. Epidemiol Infect 1992; 108 : 323-36.
9. Sneath PHA, Mair NS, Sharpe ME, Holt JG. In: Krieg NR, Holt JG, editors. Bergey's manual of systematic bacteriology. 1st ed. Baltimore, USA: Williams and Wilkins; 1986. p. 140-218.
10. PV. Comparison of chinese scheme and interanational antigenic typing system for serotyping Pseudomonas aeruginosa. J Clin Microbiol 1987; 25 : 224-6.
11. Rosenberg M, Gutinick D, Rosenberg E. Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiol Lett 1980; 9 : 29-33.
12. Mathee K, Ciofu O, Sternberg C, Lindum PW, Campbell JI, Jensen P, et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999; 145 : 1349-57.
13. Cox CD, Adams P. Siderophore activity of pyoverdin for Pseudomonas aeruginosa. Infect Immun 1985; 48 : 130-8.
14. Sokol, PA. Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia. J Clin Microbial 1986; 23 : 560-2.
15. Ankenbauer R, Sriyosachati S, Cox CD. Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun 1985; 49 : 132-40.
16. Habermann E, Hardt KL. A sensitive and specific plate test for the quantitation of phospholipases. Anal Biochem 1972; 50 : 163-73.
17. Janda JM, Bottone EJ. Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool. J Clin Microbiol 1981; 14 : 55-60.
18. Linkish, PG, Vogt W. Direct haemolytic activity of phospholipase A. Biochim Biophys Acta 1972; 270 : 241-7.
19. Hagberg L, Engberg I, Freter R, Lam J, Olling S, Svanborg Eden C. Ascending unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 1983; 40 : 273-83.
20. Kakar K, Sharma S, Asnani PJ, Banerjee CK, Sharma BK. Experimental haematogenous pyelonephritis in mice with uropathogenic, enteropathogenic and enterotoxigenic Escherichia coli. Antonie Van Leeuwenhock 1986; 52 : 153-61.
21. Garg UC, Ganguly NK, Sharma S, Chakravati RN, Bhatnagar RK. Quantitative histopathological method for evaluation of experimental ascending pyelonephritis. Med Sci Res 1987; 15 : 367-73.
22. Topley N, Steadman R, Mackenzie R, Knowlden, JM, Williams JD. Type 1 fimbriate strains of Escherichia coli initiate renal parenchymal scarring. Kidney Int 1989; 36 : 609-16.
23. Lerrer B, Gilboa-Garber N. Interactions of Pseudomonas aeruginosa PA-IIL lectin with quail egg white glycoproteins. Can J Microbiol 2001; 47 : 1095-100.
24. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4 : 80-128.
25. Domingue GJ, Laucirica R, Baliga P, Covington S, Robledo JA, Li SC. Virulence of wild-type E. coli uroisolates in experimental pyelonephritis. Kidney Int 1988; 34 : 761-5.